Drug Shortage Report for CUVITRU
| Report ID | 82602 |
| Drug Identification Number | 02461692 |
| Brand name | CUVITRU |
| Common or Proper name | Immune globulin Subcutaneous 20% |
| Company Name | TAKEDA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IMMUNOGLOBULIN |
| Strength(s) | 200MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | 1g, 2g,4g and 8g |
| ATC code | J06BA |
| ATC description | IMMUNOGLOBULINS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2019-04-09 |
| Actual start date | 2019-05-09 |
| Estimated end date | 2019-09-30 |
| Actual end date | 2019-08-23 |
| Shortage status | Resolved |
| Updated date | 2019-08-24 |
| Company comments | Shortage resolved on 2019-08-23 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2019-08-24 | English | Compare |
| v7 | 2019-08-23 | French | Compare |
| v6 | 2019-08-23 | English | Compare |
| v5 | 2019-05-10 | English | Compare |
| v4 | 2019-05-08 | French | Compare |
| v3 | 2019-05-08 | English | Compare |
| v2 | 2019-04-29 | French | Compare |
| v1 | 2019-04-29 | English | Compare |
Showing 1 to 8 of 8